Viral Factsheet From Medical Journals and Government Organizations
- Speed Media
- Jul 23, 2021
- 11 min read
Updated: Dec 8, 2024
UPDATE:
58% of women had reproductive system negatively affected by vaccine:
“Data of 586 women were included in this study. A total of 82.4% (n = 483) of the participants were aged between 31 and 50 years. The BioNTech vaccine (2 doses) was administered to 75.8% (n = 444), Sinovac (3 doses) to 9.0% (n = 53) of the participants. 53.1% (n = 311) of the women experienced changes in their menstrual cycles. The most common menstrual changes after vaccination were delayed menstruation (n = 176; 30.0%) and prolonged menstrual duration (n = 132; 22.5%). Menstrual delay, prolonged menstrual duration, heavy bleeding, and early menstruation were more common in women than prior to receiving the vaccine (P < .05). More than half of the women experienced menstrual cycle changes after receiving the COVID-19 vaccine. Women experienced significantly higher rates of menstruation delay, prolonged menstrual duration, heavy bleeding, and early bleeding compared to before vaccination.”
Covid 19 Vaccination caused mental changes and reproductive health issues in 30,000 women.
“By September 2, 2021, over 30,000 COVID-19-vaccinated females had reported menstrual changes to the MHRA's Yellow Card surveillance system. As a result, the National Institutes of Health (NIH) is urging researchers to investigate the COVID-19 vaccine's effects on menstruation.
Moreover, 524 (41.8%) were COVID-19 cases and 98 women (18.7%) reported menstrual changes (MCs). The 1,044 (83.5%) vaccinated females reported 418 (38.5%) MCs after being vaccinated, and these MCs resolved in 194 women (55.1%) after more than 9 months.”
Covid 19 Vaccines volatile relationship with Endometriosis:
“In our cohort, women with endometriosis were more likely to experience changes in bleeding patterns (women with endometriosis: 39.5%, control group: 31.0%, p = 0.02), and a significant worsening in endometriosis-associated symptoms with an almost 4.3-fold worsening in dysmenorrhea [95% CI 1.9–9.9, p < 0.01] and 5.5-fold odds for any worsening in symptoms in endometriosis patients, as compared to the control group [95% CI 2.7–11.1, p < 0.01].”
COVID 19 SARS FACT SHEET
Reinfection rate amongst non-vaccinated previously infected (7% symptomatic) March: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab234/6170939
Reinfection Rate amongst non-vaccinated 0.7% June: **see statistical limitations (1) https://medicine.missouri.edu/news/study-finds-covid-19-reinfection-rate-less-1-those-severe-illness
Delta in US in December 2020 and March: https://www.yalemedicine.org/news/5-things-to-know-delta-variant-covid
Pfizer Vaccine infections (12% symptomatic) (estimated 24% non-symptomatic infection rate) *See statistical limitations (2) https://www.nejm.org/doi/full/10.1056/NEJMoa2108891
**statistical limitations:
(1) very small group study
(2) non-symptomatic COVID 19 subjects either excluded or not tested
A 95-99% prevention rate has been reported and this is false. There is no way to determine who has been exposed to the virus at this time, and prevention should be determined by post vaccinated viral exposure vs infection, not by post vaccination population vs infection.
Efficiacy Rates Updated: July 2021
Moderna 76 percent effective preventing infection. Pfizer 42 percent effective preventing infection. Pfizer was 76% in preventing hospitalizations and Moderna was 81% effective.
Pfizer says its studies have found a decline in efficacy against symptomatic infection over time, from 95% within the first two months after getting vaccinated, to low-to-mid 80s four to six months post second dose. Pfizer is pushing to offer its own boost shot to provide better protection against variants.
Possible Antibody Decline If Booster/Second Shot Taken Too Closely:
Source 1
Initial Overlooked Findings
-Gastrointestinal distress is a common overlooked symptom of initial COVID infection when tests are negative.
-Crude prevalence of upper GI bleeding of 5.2% was found in hospitalized COVID patients.
-In addition, platelet count was normal, and secondary hemostasis parameters were unremarkable.
Source: NCBI.NLM.NIH.GOV
Breakthrough and Reinfection:
•Pfizer had the highest efficacy (95%) in clinical trials with a breakthrough rate of approximately 12-24% in recent studies.
•Moderna had high efficacy (94%) in clinical trials, no breakthrough studies currently available.
•Astra Zeneca had moderate efficacy in clinical trials and 2nd lowest efficacy.
•J&J had sub moderate efficacy in later studies.
•Pfizer, the statistically most effective vaccine yields a current symptomatic efficacy rate of approximately 88%.
•Organic infection yields a current symptomatic efficacy rate of 93%.
•Omicron Variant HIGHLY evasive of vaccines and tests but far less severe in most patients.
•Death rate is predicted to become .008% in March.
Covid Sufferers Only Need One Vaccine
One shot of a two-shot vaccine to someone who previously had COVID 19 provides more immunity to the virus than both shots do to someone who was not infected (New England Journal of Medicine)
These findings were also reflected in an analysis of antibodies against the D614G mutation and the B.1.351 South African variant of COVID-19. For those who did not have COVID-19, it took a second dose to get a robust enough immunity level against the mutation and variant, whereas those recovered from COVID-19 had a strong enough antibody response after one dose. (Penn State)
An ACS NANO study shows that individuals who have previously had COVID and get their first shot, have far more antibodies than those who have been fully vaccinated (Below) however shows little benefit from the second vaccination.
A UCLA study shows patients who recover from a coronavirus infection only need one vaccine dose to achieve full protection during the pandemic.
Death Rate Discrepancy
COVID-19 DR has been continuously reported as 2 percent for the past 2 years without change. This is incorrect and impossible. There would be some fluctuations good or bad with changing variants especially when the death rate is predicted to become .008% in March.
-The 2% figure was not including the hundreds of thousands of carriers who didn’t get tested.
-We have had protocols and better testing introduced since that were supposed to reduce the death rate by more than half, that is less than 1%.
-We have vaccines and the death rate “hasn’t decreased” though the death rate actually has in part due to vaccines and various treatments.
-The death rate not including home tests, presumed positives amongst the unvaccinated, and people sick who do not get tested is 1.4%.
-The death rate also is including deaths recorded as COVID deaths on assumption among the unvaccinated.
The death rate needs to be current. They’re including the initial blind-pandemic-phase in the death rate. We need a per-wave death rate to be more accurate. Especially with Omicron being a less severe variant (because that’s how viruses mutate. Their goal is not to kill the host within a few weeks.)
The death rate is NOT supposed to be recorded by outcome, but as deaths happen. Waiting for cases to “have an outcome” is highly inaccurate and has artificially inflated the death rate for COVID patients in a 3 month time period and possibly longer.
-According to the WHO for the past 2 weeks, the USA has had a case increase of 84% and a death increase of 0%.
The current death rate for the WORLD is 0.4%. The death rate for the US is currently 0.45%. You currently have a 0.4% chance of dying from COVID.
“This also does not mean that 2 out of every 200 people will die of COVID. This means that 2 out of every 200 people that are actually tested for COVID will die of COVID, and this number varies greatly by age group.” -Statistical Analyst
Further Notes
No reinfection studies have been done on individuals who have had both COVID 19 and Vaccines, however re-infection amongst vaccinated and previously infected individuals have been reported, these people may have JAK3 deficiencies, however doctors are highly unlikely to test for JAK3 deficiencies for various reasons.
There is only so much vaccination and infection can do for individuals with immunological deficits, but using both vaccination and infection have yielded a lesser consequence of reinfection except in extremely rare cases.
No studies have been peer reviewed for the risks of exposing the body to immune inflammation via vaccine after infection which was why waiting 60-90 days (or until completely recovered per the CDC) was initially recommended. However, since some long-haul COVID suffering individuals are made better either temporarily or longer by the shot, this suggests promising results from vaccinating long haul suffering individuals, though a few doctors recommend their still unhealthy patients wait.
Since an immune response triggered relief of long-COVID, this reaction suggests autoimmune activity exists from SARS during the viral shedding period months after initial infection. These symptoms may even return a month after the vaccination period ends, but this is not founded except anecdotally on COVID 19 Survivor support forums and makes for the minority of commenters on the issue.
In short, the immune system is attacking more vaccine than organic human cells, and when the spike protein or virus is gone auto-immune response in individuals prone to auto immune flares may “flare” again, though no studies specific to COVID 19 have definitively proven this.
Disclaimer
Always consult with your physician who knows you best if you are making a decision and be weary of facebook fast-facts from unverified sources, per the CDC.
No studies have been posted regarding non-symptomatic vaccinated carriers, or the information was deemed unnecessary for prioritization purposes, thou non-symptomatic carriers are included in organic reports.
Vaccinated individuals can carry COVID-19 to unvaccinated individuals, per multiple studies and the CDC. This was known, as vaccines do not cover clothing and products brought into the household, however it has been recently discovered that vaccinated individuals can successfully carry the virus without being symptomatic.
Strain Information
Original Strain: January 9th 2019 Detected in Wuhan, China
Variants:
Alpha B.1.1.7 Detected in Southern England in 2020
Beta B.1.351 Detected in Southern Africa in 2020
Gamma P.1 Detected in the US in 2021
Kappa B.1.617.1 Detected in India in 2020
Delta B.1.617.2 Detected in India in 2020 (60% more transmissible than alpha.)
B.1.526 Lota
Lambda C.37 Detected in Peru December 2020 (55% more transmissible than alpha)
Mu B.1.621 Detected in Columbia in January of 2021 making up 9% of cases in Miami. C.1.2 is a variant detected in South Africa in August of 2021. The W.H.O. is not concerned with this variant at this time.
Omicron Variant origin unknown, November 26th 2021, labeled a variant of concern.
Delta Variant harder to detect: https://www.kitchenertoday.com/coronavirus-covid-19-local-news/delta-covid-variant-harder-to-detect-
Omicron The Great Mistake
Ravindra Gupta, Professor of Clinical Microbiology at the Cambridge Institute for Therapeutic Immunology and Infectious Diseases (CITIID) states that Omicrons evolution is a mistake and that the virus has no reason to be mild.
“Evolution-wise viruses without vaccination usually become milder over time. Killing the host is not the goal, replication is, and this variant of the virus lasts longer, statistically, but is more mild -which is the goal of most viruses or anything trying to thrive. It’s not an evil living thing whose goal is to wipe out humanity. It’s not alive or dead. It’s just a piece of genetic material that is trying to replicate effectively.”
-Statistical Analyst
Statistical Breakdown:
*Delta results in 95% of new cases as of July 2021 but is not easily detectable via PCR testing, so less symptomatic or low-viral-load carriers will likely not be detected with Delta, as non-symptomatic carriers not only will not be tested, but the testing protocols maintain difficulty detecting Delta leading to initially negative tests in some symptomatic carriers in the first stage of the virus.
*Delta infection rate is compared to Pre-Alpha base COVID instead of parent variant.
Strange facts on Delta:
•Olefactory disruptions seemingly not as common
•Gastrointestinal disruptions more common
•Sore throat is more common
•Infection rate is higher due to viral tissue density
•Delta seems to target the lungs, making people with lung disease and smokers more vulnerable, in both non vaccinated, vaccinated and previously infected populations amongst vaccinated populations and amongst previously infected COVID 19 patients.
•The large gap between organic and vaccination efficacy is due to man-made scientific imperfection and the fact that there is no current vaccine that was manufactured to cover any strain of the virus beyond B.1.1.7. There is no way to be completely immune to any strain and infection is not recommended due to a 30% hospitalization rate and a 3% death rate.
•Though few hospitalizations exist for the vaccine, no hospitalization rates against vaccine side effects have been recorded or considered for study, but the UK has a significant lesser vaccination negative side-effect rate due to medical competence during vaccination. More reports of temporary nerve damage, recurring arm pain over a period of months due to incorrectly placed jabs in the states have been reported.
Pregnancy:
There are far more reported and linked miscarriages in COVID 19 patients than vaccination patients, however studies have shown the following.
Injection Site Pain more common in pregnant women
Flu-like symptoms less common in pregnant women
13.9% experiences pregnancy loss which is below the normal miscarriage rate of 15% amongst pre-COVID non vaccinated individuals
12.6% experienced neonatal abnormalities which is above the normal neonatal abnormality rate of 4%.
Of over 3000 participants, only 277 participants experienced adverse outcomes beyond the norm, and most were due to neonatal abnormalities.
Based on this study, the results indicate a 7% higher risk of adverse effect with the vaccine.
The study notes that this data isn’t enough to determine actual risk. Please discuss vaccination with your primary care provider as recommended by the CDC.
**Vaccine Case Study:
N Engl J Med 2021; 384:2273-2282
DOI: 10.1056/NEJMoa2104983
**Pre COVID 19 vaccination data obtained from the Centers For Disease Control.
• Reports on miscarriages due to the vaccine are heavily scrutinized and usually not reported as an adverse side effect because there are less miscarriages with the vaccine than without. All miscarriages however in a COVID positive mother are linked to COVID due to futility in differentiation.
•Pregnancy is continuing to be studied for Moderna, Pfizer and J&J. Studies are not definitive as they are not broad enough, however this is an emergency situation thus an emergency and voluntary vaccine.
Anyone pregnant taking the vaccine is considered under study. Though the vaccine has not passed the three year study threshold, COVID 19 has been reported to cause more miscarriages than the vaccine by a significant margin.
Rumors
Due to the lack of convincing information, pregnant women are no longer discouraged from the vaccination, but non-pregnant women on birth control have been rumored to get pregnant after taking the shot, showing that the bodies immune response to the vaccination may cause a drastic enough fluctuation in hormones to override birth control or promote fertility, but this is not officially studied or officially confirmed.
Other Information
-This vaccine was not in development for 20 years. It is a combination of research from previous strains of SARS and CORONA viruses.
-COVID viruses existed previously but rarely caused anything other than epidemics.
-COVID 19 is SARS, not the flu.
-Personal note: If we would’ve called this virus SARS from the beginning, half of you would’ve actually taken it seriously, and that’s disappointing.
-Ivermectin is an anti parasitic drug that has not been studied for use with COVID. COVID can cause individuals to be vulnerable to conditions that ivermectin is used to treat, however, it has not been approved or authorized for use by the CDC, and individuals are being hospitalized for using horse-grade ivermectin de-worming-paste instead of the human-grade tablets, according to the FDA.
**Grant criteria limitation and lack of peer reviewing hinders research in all areas. Research can be costly and this is a very taxing and rapidly developing situation. We will all get there eventually.
***Peer review does not often involve laboratory review, and can also be funded by individuals requesting peer review leaving room for conflicts of interest.
Ingredients
Pfizer: (30mcg pdx21d)
((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis
(2-hexyldecanoate)
2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide
1,2-Distearoyl-snglycero-3- phosphocholine
potassium chloride
monobasic potassium phosphate
sodium chloride
dibasic sodium phosphate dihydrate
sucrose,
Moderna (100mcg pdx28d)
mRNA
SM-102
1,2-dimyristoyl-rac-glycero3-methoxypolyethylene glycol-2000 [PEG2000-DMG]
cholesterol
1,2-distearoyl-snglycero-3-phosphocholine [DSPC]
Acetic acid
Tromethamine & Tromethamine hydrochloride
Sodium acetate
J&J (1xd)
citric acid
monohydrate trisodium citrate dihydrate
2-hydroxypropyl-β-cyclodextrin (HBCD
polysorbate-80
sodium chloride
ethanol.
It uses adenovirus with COVID DNA which transcribes to mRNA.
FDA APPROVAL
The vaccines were initially not FDA approved. They were authorized for emergency use. This is done when there is not enough time to test a vaccine, and this is necessary to prevent mass deaths during pandemics.
On August 23rd, Pfizer was approved by the FDA.
The FDA, Fauci and the Whitehouse are in extreme disagreement regarding boosters and vaccinations for children under the age of 11. FDA officials are threatening to step down and resign over the pressure that is being placed to rush approvals for the vaccines.
Source: CDC
Updated Various Materials Awaiting Peer Review
-Covid 19 Patients equally likely to be re-infected as vaccinated patients are to be infected. (Cleveland Clinic)***
Comments